Fibromyalgia

Alpha(1)-antitrypsin replacement therapy controls FM symptoms in two sisters

Published in Women's Health Weekly, December 16th, 2004

When two sisters with alpha(1)-antitrypsin (AAT) deficiency and fibromyalgia (FM) were placed on AAT replacement therapy, their physicians noted that their FM symptoms were relieved and controlled.

After beginning commercial alpha(1)-antitrypsin infusions in 1992, both sisters "experienced a rapid, progressive, and constant control of their FM symptoms during the next 6 years (1992-98)," reported I. Blanco and colleagues, Hospital Valle Nalon, Asturias, Spain.

"However, in 1998, treatment of both patients was affected by the worldwide commercial shortage of AAT replacement therapy; replacement therapy infusions were halted for about 4-6 consecutive...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2004-12-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry